News

Zogenix and Desitin Pharma claim Sumavel DosePro offers fast acting, easy-to-use, needle-free subcutaneous administration of sumatriptan. Sumavel DosePro may offer a treatment alternative to oral and nasal triptans,

The integration helps to enable complete real-time patient electronic medical records (EMRs) at the Canadian Healthcare facility. Streamline Health’s integrated solution is designed to deliver improved efficiencies by

Orbus Pharma’s Cambridge facility is an antibiotics facility which has the current capacity of >50 million capsules or tablets per year with existing equipment. The purchase price of

The partnership has resulted in the creation of new products that have made pre- and post-transplant diagnostics faster, and more cost-efficient. One Lambda has adopted Luminex’s xMAP technology

The license includes a carve-out by BIG for use of the technology in its non-Hodgkin lymphoma (NHL) vaccine which is currently under development. The license leaves Stellar free

SQ109 is currently in Phase II clinical study in patients with pulmonary TB and based on the Phase 1 results achieved under its TB IND, Sequella will conduct

Selcia managing director Hans Fliri said that they can now offer pharmaceutical and biotech companies cost effective radiolabelling services to support both the pre-clinical and clinical development of

Apexigen will generate and screen antibodies to several targets specified by Centocor R&D, which will be responsible for development and commercialization of all products resulting from the collaboration.

Emerflu was intended to be used for prophylaxis of influenza in an officially declared pandemic situation. Sanofi Pasteur has submitted the marketing authorisation application to the European Medicines